Quest Diagnostics (DGX) Income from Non-Controlling Interests (2009 - 2026)

Quest Diagnostics' (DGX) quarterly Income from Non-Controlling Interests came in at $12.0 million in Q1 2026, down 20.0% year-on-year from $15.0 million in Q1 2025, and up 9.09% quarter-over-quarter from $11.0 million in Q4 2025.

Quest Diagnostics (DGX) Income from Non-Controlling Interests (2009 - 2026) Analysis & Trends

Quest Diagnostics has disclosed Income from Non-Controlling Interests across 18 years of filings, most recently posting $12.0 million for Q1 2026.

  • Income from Non-Controlling Interests for Q1 2026 came in at $12.0 million, down 20.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $51.0 million (changed 0.0% YoY), and the FY2025 annual result was $54.0 million, up 8.0% from the prior year.
  • Income from Non-Controlling Interests came in at $12.0 million for Q1 2026 at Quest Diagnostics, up from $11.0 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $20.0 million in Q3 2022 to a low of $11.0 million in Q2 2024.
  • The 5-year median for Income from Non-Controlling Interests is $14.0 million (2023), against an average of $14.1 million.
  • Across the five-year window, Income from Non-Controlling Interests tumbled 40.0% in 2023 and climbed 27.27% in 2025, its largest moves.
  • Quest Diagnostics' Income from Non-Controlling Interests stood at $15.0 million in 2022, then slipped by 13.33% to $13.0 million in 2023, then grew by 7.69% to $14.0 million in 2024, then retreated by 21.43% to $11.0 million in 2025, then climbed by 9.09% to $12.0 million in 2026.
  • The last three Income from Non-Controlling Interests figures came in at $12.0 million (Q1 2026), $11.0 million (Q4 2025), and $14.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Waters 29,902.70 Bn 29,902.24 Bn 1.11 Bn -
2 Thermo Fisher Scientific 175.99 Bn 172.74 Bn 7.74 Bn 5.00 Mn
3 Danaher 129.87 Bn 124.18 Bn 3.59 Bn -
4 Idexx Laboratories 44.75 Bn 44.55 Bn 722.74 Mn -
5 Agilent Technologies 37.52 Bn 35.72 Bn 990.00 Mn -
6 Iqvia Holdings 30.91 Bn 28.94 Bn 1.36 Bn 1.00 Mn
7 Natera 30.21 Bn 29.11 Bn 696.04 Mn -
8 Illumina 24.19 Bn 23.04 Bn 721.00 Mn -
9 Mettler Toledo International 23.12 Bn 23.06 Bn 555.82 Mn -
10 Quest Diagnostics 21.68 Bn 21.59 Bn 942.00 Mn 12.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.00 Mn
Dec 31, 2025 11.00 Mn
Sep 30, 2025 14.00 Mn
Jun 30, 2025 14.00 Mn
Mar 31, 2025 15.00 Mn
Dec 31, 2024 14.00 Mn
Sep 30, 2024 11.00 Mn
Jun 30, 2024 11.00 Mn
Mar 31, 2024 14.00 Mn
Dec 31, 2023 13.00 Mn
Sep 30, 2023 12.00 Mn
Jun 30, 2023 14.00 Mn
Mar 31, 2023 15.00 Mn
Dec 31, 2022 15.00 Mn
Sep 30, 2022 20.00 Mn
Jun 30, 2022 16.00 Mn
Mar 31, 2022 18.00 Mn
Dec 31, 2021 23.00 Mn
Sep 30, 2021 22.00 Mn
Jun 30, 2021 19.00 Mn